ArticleAntimicrobial agents and chemotherapy2025

Pharmacokinetics, safety, and tolerability of onradivir in participants with severe renal impairment and matched healthy control participants.

Haijun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.